Prio Wealth Limited Partnership’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $1.45M | Sell |
49,939
-3,528
| -7% | -$103K | 0.04% | 131 |
|
|
2024
Q2 | $1.5M | Sell |
53,467
-15,853
| -23% | -$436K | 0.04% | 127 |
|
|
2024
Q1 | $1.92M | Buy |
69,320
+5,621
| +9% | +$156K | 0.06% | 123 |
|
|
2023
Q4 | $1.83M | Sell |
63,699
-21,880
| -26% | -$661K | 0.06% | 115 |
|
|
2023
Q3 | $2.84M | Sell |
85,579
-8,545
| -9% | -$302K | 0.11% | 99 |
|
|
2023
Q2 | $3.45M | Sell |
94,124
-1,804
| -2% | -$70.2K | 0.12% | 94 |
|
|
2023
Q1 | $3.91M | Sell |
95,928
-10,689
| -10% | -$462K | 0.15% | 89 |
|
|
2022
Q4 | $5.46M | Sell |
106,617
-213
| -0.2% | -$10.2K | 0.22% | 79 |
|
|
2022
Q3 | $4.67M | Sell |
106,830
-11,509
| -10% | -$559K | 0.2% | 81 |
|
|
2022
Q2 | $6.2M | Sell |
118,339
-2,980
| -2% | -$152K | 0.25% | 78 |
|
|
2022
Q1 | $6.28M | Buy |
121,319
+242
| +0.2% | +$12.6K | 0.21% | 81 |
|
|
2021
Q4 | $7.15M | Sell |
121,077
-917
| -0.8% | -$45.4K | 0.22% | 80 |
|
|
2021
Q3 | $5.25M | Buy |
121,994
+1,181
| +1% | +$52.3K | 0.18% | 88 |
|
|
2021
Q2 | $4.73M | Sell |
120,813
-3,217
| -3% | -$125K | 0.16% | 88 |
|
|
2021
Q1 | $4.49M | Sell |
124,030
-7,736
| -6% | -$275K | 0.16% | 86 |
|
|
2020
Q4 | $4.85M | Sell |
131,766
-4,475
| -3% | -$164K | 0.18% | 80 |
|
|
2020
Q3 | $4.74M | Sell |
136,241
-2,036
| -1% | -$71.4K | 0.2% | 76 |
|
|
2020
Q2 | $4.29M | Sell |
138,277
-5,076
| -4% | -$172K | 0.2% | 77 |
|
|
2020
Q1 | $4.44M | Sell |
143,353
-30,937
| -18% | -$1.05M | 0.24% | 74 |
|
|
2019
Q4 | $6.48M | Sell |
174,290
-27,510
| -14% | -$980K | 0.27% | 74 |
|
|
2019
Q3 | $6.88M | Sell |
201,800
-195,520
| -49% | -$7.11M | 0.31% | 72 |
|
|
2019
Q2 | $16.3M | Sell |
397,320
-675,635
| -63% | -$26.8M | 0.75% | 42 |
|
|
2019
Q1 | $43.2M | Sell |
1,072,955
-20,152
| -2% | -$807K | 2.03% | 14 |
|
|
2018
Q4 | $45.3M | Sell |
1,093,107
-2,689
| -0.2% | -$112K | 2.41% | 8 |
|
|
2018
Q3 | $45.8M | Buy |
1,095,796
+33,802
| +3% | +$1.3M | 2.09% | 12 |
|
|
2018
Q2 | $36.6M | Sell |
1,061,994
-32,484
| -3% | -$1.11M | 1.81% | 17 |
|
|
2018
Q1 | $36.9M | Sell |
1,094,478
-93,065
| -8% | -$3.2M | 1.84% | 18 |
|
|
2017
Q4 | $40.8M | Sell |
1,187,543
-1,802
| -0.2% | -$61.4K | 1.9% | 15 |
|
|
2017
Q3 | $40.3M | Sell |
1,189,345
-23,687
| -2% | -$761K | 1.97% | 13 |
|
|
2017
Q2 | $38.7M | Sell |
1,213,032
-22,860
| -2% | -$721K | 1.93% | 13 |
|
|
2017
Q1 | $40.1M | Buy |
1,235,892
+5,872
| +0.5% | +$185K | 2.06% | 11 |
|
|
2016
Q4 | $37.9M | Buy |
1,230,020
+259,564
| +27% | +$7.92M | 2.03% | 11 |
|
|
2016
Q3 | $31.2M | Buy |
970,456
+12,980
| +1% | +$434K | 1.66% | 19 |
|
|
2016
Q2 | $32M | Buy |
957,476
+51,464
| +6% | +$1.64M | 1.75% | 17 |
|
|
2016
Q1 | $25.5M | Buy |
906,012
+589,585
| +186% | +$16.8M | 1.39% | 25 |
|
|
2015
Q4 | $9.69M | Buy |
316,427
+5,699
| +2% | +$179K | 0.53% | 58 |
|
|
2015
Q3 | $9.26M | Buy |
310,728
+1,051
| +0.3% | +$33.7K | 0.53% | 58 |
|
|
2015
Q2 | $9.85M | Sell |
309,677
-12,074
| -4% | -$394K | 0.51% | 62 |
|
|
2015
Q1 | $10.6M | Sell |
321,751
-6,825
| -2% | -$217K | 0.52% | 63 |
|
|
2014
Q4 | $9.71M | Sell |
328,576
-5,642
| -2% | -$162K | 0.48% | 63 |
|
|
2014
Q3 | $9.38M | Sell |
334,218
-1,597
| -0.5% | -$44.8K | 0.48% | 63 |
|
|
2014
Q2 | $9.46M | Sell |
335,815
-13,607
| -4% | -$388K | 0.48% | 64 |
|
|
2014
Q1 | $10.6M | Buy |
349,422
+6,215
| +2% | +$185K | 0.54% | 59 |
|
|
2013
Q4 | $9.97M | Sell |
343,207
-4,038
| -1% | -$118K | 0.5% | 61 |
|
|
2013
Q3 | $9.46M | Buy |
347,245
+4,219
| +1% | +$115K | 0.54% | 55 |
|
|
2013
Q2 | $9.12M | Buy |
+343,026
| New | +$9.48M | 0.55% | 59 |
|
Other funds holding PFE
Prio Wealth Limited Partnership's PFE Position: Q3 2024 in Review
Prio Wealth Limited Partnership reduced its Pfizer (PFE) stake by 6.6% in Q3 2024, selling an estimated $103K and leaving 49,939 shares worth $1.45M. The position accounts for 0.04% of the portfolio, ranked #131.
Prio Wealth Limited Partnership first reported a position in PFE in Q2 2013 and has held it in 46 quarters since. The position peaked at $45.8M in Q3 2018. 2,909 funds tracked by Wall St. Rank hold PFE as of Q3 2024.
- Prio Wealth Limited Partnership held 49,939 shares of Pfizer worth $1.45M as of Q3 2024.
- Prio Wealth Limited Partnership sold 3,528 Pfizer shares in Q3 2024, an estimated $103K.
- Pfizer made up 0.04% of Prio Wealth Limited Partnership's portfolio in Q3 2024, its #131 holding.
- Prio Wealth Limited Partnership first reported a position in Pfizer in Q2 2013 and has held it in 46 quarters since.
- Prio Wealth Limited Partnership's Pfizer position peaked at $45.8M in Q3 2018.
- 2,909 funds tracked by Wall St. Rank held Pfizer as of Q3 2024.
Based on Prio Wealth Limited Partnership's 13F filing for Q3 2024, filed 21 Oct 2024.